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C 5 maleimide and Alexa Fluor 594 C 5 maleimide were used in these reactions. The labelled protein was purified from unreacted dye using the method reported in Cremades et al., 2012 1 .
The reaction yield was checked by mass spectrometry, and proteins labelled less than the 90% were not used in experiments. In order to avoid confusion with unlabelled proteins used in other experiments, labelled A90C, A53T-A90C, A30P-A90C and E46K-A90C will be defined as WT*, A53T*, A30P* and E46K*.
Protein aggregation for Thioflavin T assay. The A53T and A30P pathological aS variants have been reported to have a shorter lag-phase and a longer lag-phase, respectively, than the WT protein for their aggregation reaction in vitro (A53T>WT>A30P) 2 . In order to confirm the different aggregation propensities of the aS mutants are maintained upon the aggregation conditions used for smFRET, a Thioflavin T assay was performed using unlabelled protein, absorbance is slow until a visible pellet is observed (arrows in Figure S2A ), at which point it decreased rapidly, indicating that monomers are also able to directly add to fibrils 3 . The experiment was stopped after the deposition of a pellet upon centrifugation but generally two smFRET time-points are analysed after the detection of the protein pellet. There is a small delay compared to the unlabelled protein Thioflavin T assay in Figure S1 , but the ability of the protein to aggregate is not affected by the fluorescent tag, as checked by TEM on the pellet formed upon centrifugation ( Figure S3 ). We then divided the time window for the analysis in two parts: "lag-phase", where no fibrils are present, corresponding to the first days of reaction for WT* and A53T* and the first 48 hours for A30P* (5 time-points for each variant) and "end of the lag-phase", corresponding to the three time-points where the fibrils pellet starts to be visible (30 ± 2 hours, for A53T* at 26 ± 2 hours and for A30P* at 72 ± 16 hours).
S5
Transmission Electron Microscope imaging. For TEM imaging, WT* labelled with AlexaFluor488 only, or AlexaFluor594 or the equimolar mixture both, were incubated under aggregating conditions. 10 µl of each sample were taken after 48 hours of incubation and applied onto carbon-coated 400-mesh copper grids (Agar Scientific) for 5 min, and then washed with distilled water. Negative staining was carried out by using 2 % (w/v) uranyl acetate. TEM images were acquired using Tecnai G2 microscope (13218, EDAX, AMETEK)
operating at an excitation voltage of 200 kV.
Production of microfluidic devices. Microfluidic devices have been prepared as previously surface via spin-coating (800 rpm for 5 s and then ramped to 3000 rpm at an acceleration of 300 rpm/s for 60 s). The final film thickness was 25 µm, measured by profilometry (DekTak 150). After spinning, the wafer was incubated 1 min at 65°C, then 3 min at 95°C and finally 1 min at 65°C, and then exposed to UV light through the mask on a mask aligner (MJB4, SUSS Microtec). After post-baking and development, the master was incubated for 1 min at 170°C.
PDMS and curing agent (Sylgard 184, Dow Corning) in a 10/1 w/w ratio were poured over the master, degassed and baked at 75°C at least 2 hours. The devices were separated from the master and cut, using a biopsy punch to introduce access holes for the inlet tubes. The devices were then exposed to oxygen plasma for 7 s (DienerFemto plasma asher), sealed to a glass microscope slide and baked overnight at 75°C.
Calculation of the gamma factor () and association quotient (Q) used for data analysis.
The correction factor (γ) was calculated using a solution of labelled AlexaFluor488 and AlexaFluor594 aS at concentrations enabling the dyes to yield the same absorption at 488 nm (Varian Eclipse Spectrophotometer). The solution was then measured in bulk on the singlemolecule instrument, giving γ = 1.01 according to:
where I D and I A are the intensities in the donor and acceptor channels 5 .
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Q is the association quotient used to report the ratio of the rate of coincident events to the sum of the rate of all events in the donor and acceptor channels, subtracting the chance coincident events as indicated 6 :
where A and B are the event rates (s -1 ) in donor and acceptor channels and C the observed rate of coincident events, and the estimated rate at which coincident events occur by chance (E) is
where is the interval time in seconds.
Fitting data to model equation.
A general kinetic model 7 can be used to fit the kinetics of the early stages of amyloid fibril formation observed in aS smFRET data. Some assertions are considered in the design of this model:
-two classes of oligomeric intermediates (type-A and type-B) are considered explicitly;
while type-B oligomers are partly structured and present characteristics closer to amyloid fibrils, type-A oligomers are less stable compared to type-B and structurally distinct from the former species 1 .
-Both type-A and type-B oligomers can grow through monomer addition, and undergo the inverse phenomenon of monomer dissociation.
-There is no direct nucleation of type-B structures from monomer.
-Type-A oligomers of a given number of monomers can convert into type-B structures.
The time evolution describing the number concentration, growth and time evolution of type-A and B oligomers can be written in terms of primary nucleation, elongation and interconversion between species. The equations for number concentrations of oligomer types A and B are obtained summing over all possible oligomer lengths. We restrict the application of the equations to the system only to the period before the bulk lag-time for fibril formation, τ lag , as the concentration is approximately constant at its initial value due to the fact that only few monomers have been engaged into aggregates. In this regime, many processes as reverse conversion from type-B to A depolymerisation, accounted for in the master equation, do not have a significant effect on the number-concentrations of oligomers and can be ignored.
Under these conditions, the number concentration equations can be written as:
where Q is the number concentration of oligomers of type-A, k n type-A oligomer formation rate, m tot monomer concentration, k c type-A oligomers conversion rate and P the concentration of type-B oligomers. These can then be solved in closed form, giving the solutions for the number concentrations as follows: Equations S6 and S7 up to the lag-time and fits were obtained using the two kinetic parameters k n ' and k c . τ lag has been identified through the measure of bulk soluble monomer concentration shown in Figure S2 . In order to fit data, data expressed in "fraction of events" have been multiplied by initial monomer concentration (70 µM) to provide an estimation of oligomers molarity ( Figure S4 ). The results of the fitting are reported in Figure S4 (continuous lines); curves were obtained setting k n ' and k c as 5·10 
